These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer. Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493 [TBL] [Abstract][Full Text] [Related]
47. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography. Ozkol V; Alper E; Aydin N; Ozkol HF; Topal NB; Akpinar AT Nucl Med Commun; 2010 Feb; 31(2):128-36. PubMed ID: 19858768 [TBL] [Abstract][Full Text] [Related]
48. Effective methods to correct contrast agent-induced errors in PET quantification in cardiac PET/CT. Büther F; Stegger L; Dawood M; Range F; Schäfers M; Fischbach R; Wichter T; Schober O; Schäfers KP J Nucl Med; 2007 Jul; 48(7):1060-8. PubMed ID: 17574981 [TBL] [Abstract][Full Text] [Related]
49. Spectrum of (18)F-FDG PET/CT appearances in peritoneal disease. Anthony MP; Khong PL; Zhang J AJR Am J Roentgenol; 2009 Dec; 193(6):W523-9. PubMed ID: 19933627 [TBL] [Abstract][Full Text] [Related]
50. Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows. Beyer T; Rosenbaum S; Veit P; Stattaus J; Müller SP; Difilippo FP; Schöder H; Mawlawi O; Roberts F; Bockisch A; Kühl H Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1429-39. PubMed ID: 16133383 [TBL] [Abstract][Full Text] [Related]
51. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer. Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773 [TBL] [Abstract][Full Text] [Related]
52. PET and PET/CT in pediatric oncology. Jadvar H; Connolly LP; Fahey FH; Shulkin BL Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239 [TBL] [Abstract][Full Text] [Related]
53. Metformin may be associated with false-negative cancer detection in the gastrointestinal tract on PET/CT. Steenkamp DW; McDonnell ME; Meibom S Endocr Pract; 2014 Oct; 20(10):1079-83. PubMed ID: 25100379 [TBL] [Abstract][Full Text] [Related]
54. Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI. Hong HR; Jin S; Koo HJ; Roh JL; Kim JS; Cho KJ; Choi SH; Nam SY; Kim SY J Surg Oncol; 2014 Nov; 110(6):696-701. PubMed ID: 24995957 [TBL] [Abstract][Full Text] [Related]
55. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771 [TBL] [Abstract][Full Text] [Related]
56. Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study. Kauhanen S; Rinta-Kiikka I; Kemppainen J; Grönroos J; Kajander S; Seppänen M; Alanen K; Gullichsen R; Nuutila P; Ovaska J J Nucl Med; 2015 Aug; 56(8):1163-8. PubMed ID: 26045314 [TBL] [Abstract][Full Text] [Related]
57. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role? Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774 [TBL] [Abstract][Full Text] [Related]
58. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients. Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850 [TBL] [Abstract][Full Text] [Related]
59. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors. Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363 [TBL] [Abstract][Full Text] [Related]
60. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Andrade RS; Heron DE; Degirmenci B; Filho PA; Branstetter BF; Seethala RR; Ferris RL; Avril N Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1315-22. PubMed ID: 16750327 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]